Demographics of All Study Subjects.

<p>Demographics of All Study Subjects.</p

60 Day Mortality by Intention to Treat Analysis.

<p>* Does not include six subjects LTFU (002–003, 011–002, 004–007, 011–004, 013–002, 007–025).</p><p>60 Day Mortality by Intention to Treat Analysis.</p

Baseline characteristics of the riCa and non-riCa vs. control subset of patients.

<p>Baseline characteristics of the riCa and non-riCa vs. control subset of patients.</p

60 Day Mortality of Subjects–Recommended Ionized Calcium Range (riCa).

<p>* Three subjects LTFU.</p><p>60 Day Mortality of Subjects–Recommended Ionized Calcium Range (riCa).</p

Mortality or Dialysis Dependency at Day 60 –Recommended Ionized Calcium Range.

<p>Mortality or Dialysis Dependency at Day 60 –Recommended Ionized Calcium Range.</p

Inclusion criteria.

<p>Inclusion criteria.</p

Summary of Site-reported Serious Adverse Events (SAEs).

<p>* Two subjects enrolled to CRRT alone arm (012–002, 003–015) however not treated.</p><p>Summary of Site-reported Serious Adverse Events (SAEs).</p

Exclusion Criteria.

<p>Exclusion Criteria.</p